• Users Online: 129
  • Print this page
  • Email this page
Year : 2023  |  Volume : 7  |  Issue : 1  |  Page : 13-20

Evaluation of drug standards, quality control, and trade in medicinal plants

1 Former Secretary, ISM&H (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi, India
2 Chief Scientific Officer, Ayurvidye Trust Bengaluru and Chairman, Herbals Committee of Indian Pharmacopeia Commission, Ministry of Health &Family Welfare, Government of India, New Delhi, India

Correspondence Address:
Ms. Shailaja Chandra
Former Secretary ISM&H (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jras.jras_151_22

Rights and Permissions

This article is about the importance of medicinal plants in the manufacture of Ayush formulations or exported as raw drugs. Granting a license to manufacture, conducting quality control tests, and enforcing the legal provisions of the Drugs & Cosmetics (D&C) Act 1940 are the responsibilities of the relevant statutory regulatory bodies. The main stakeholders responsible for ensuring the products' quality, safety, and effectiveness are licensed manufacturers who have to follow the standards prescribed under the statutory regulations. The widespread interest in Ayurvedic drugs and other plant-based products led to this appraisal of the achievements and challenges of the regulatory bodies and those responsible for accelerating the organised cultivation of medicinal plants for domestic use and for export.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded172    
    Comments [Add]    

Recommend this journal